GAPDH and ovarian serous adenocarcinoma: In order to validate the gene-expression levels from the microarray experiments, we performed real-time qRT–PCR with GAPDH as a control in five normal ovaries, three LMP ovarian serous cancers, five primary ovarian serous cystadenocarcinomas and two omental metastases.